These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 2093781

  • 1. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B, Krznarić Z, Sentić M, Milicić D, Korać B, Cvorisćec D, Stavljenić A.
    Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
    [Abstract] [Full Text] [Related]

  • 2. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
    Vucelić B, Milicić D, Krznarić Z, Korać B, Sentić M, Hadzić N, Stavljenić A, Cvorisćec D.
    Acta Med Austriaca; 1991; 18(4):100-5. PubMed ID: 1722373
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997 Nov; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 5. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 6. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn EG, Raithel M.
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [Abstract] [Full Text] [Related]

  • 8. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H.
    Nutrition; 2008 Dec; 24(7-8):694-702. PubMed ID: 18499398
    [Abstract] [Full Text] [Related]

  • 9. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S, Florén CH, Lindhagen T, Starck M, Stewenius J, Nässberger L.
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [Abstract] [Full Text] [Related]

  • 10. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C, Boirivant M, De Toma G, Cerci S, Subioli S, Scuro L, Ferrari P, Pallone F.
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [Abstract] [Full Text] [Related]

  • 11. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
    Schmitz-Moormann P, Himmelmann GW, Brandes JW.
    Pathol Annu; 1985 Jun; 20 Pt 1():281-301. PubMed ID: 3991239
    [Abstract] [Full Text] [Related]

  • 12. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 13. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 14. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D, Pawlica D, Ciećko-Michalska I, Solnica B, Mach T.
    Przegl Lek; 2010 Jan; 67(2):114-8. PubMed ID: 20557011
    [Abstract] [Full Text] [Related]

  • 15. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I, Fedak D, Mach T.
    Przegl Lek; 2010 Jan; 67(12):1262-5. PubMed ID: 21591350
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study.
    Goebell H, Wienbeck M, Schomerus H, Malchow H.
    Med Klin (Munich); 1990 Oct 15; 85(10):573-6. PubMed ID: 2233586
    [Abstract] [Full Text] [Related]

  • 17. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?
    Zissis M, Afroudakis A, Galanopoulos G, Palermos L, Boura X, Michopoulos S, Archimandritis A.
    Am J Gastroenterol; 2001 Jul 15; 96(7):2177-83. PubMed ID: 11467650
    [Abstract] [Full Text] [Related]

  • 18. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K, Berger M, Niederau C, Frieling T.
    Hepatogastroenterology; 1999 Jul 15; 46(28):2309-14. PubMed ID: 10521988
    [Abstract] [Full Text] [Related]

  • 19. [Value of alpha-1-antitrypsin and thrombocytes in the assessment of inflammatory activity in Crohn disease].
    Tromm A, Hüppe D, Straub H, Krieg M, May B.
    Med Klin (Munich); 1992 Feb 15; 87(2):53-7. PubMed ID: 1542282
    [Abstract] [Full Text] [Related]

  • 20. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P, Grunebaum L, Wiesel ML, Sibilia J, Coumaros G, Wittersheim C, Baumann R, Cazenave JP.
    Am J Gastroenterol; 1998 Apr 15; 93(4):610-4. PubMed ID: 9576457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.